ABOUT THE FOUNDER

Dr. Anthony Alsayed is a distinguished multi-specialist physician and academic leader with over 25 years of international excellence spanning clinical medicine, research, and higher education. He holds an MD, a Ph.D. in Clinical Research, and advanced specializations in Internal Medicine, Sleep Medicine, Immunology-Allergy, and Ultrasonography. Uniquely positioned at the convergence of medicine and technology, Dr. Alsayed complements his deep clinical foundation with cutting-edge credentials as a Certified AI Expert, alongside advanced certifications in Strategic Healthcare Leadership and Harvard Higher Education Teaching.

As the former Director of Clinical Research and Government Affairs at CSI Research and MegaMed Research Canada, he has extensive experience executing high-impact clinical trial protocols across multiple therapeutic areas in partnership with leading pharmaceutical companies, including Pfizer, Sanofi, Roche, and Merck. This industry-side perspective informs his work in driving innovation in clinical trial design and healthcare delivery.

An accomplished educator, Dr. Alsayed has lectured at Northeastern University and brings quadrilingual teaching experience (English, French, Russian, and Lebanese) across North America and Europe. His commitment to educational innovation has earned him multiple accolades, including the prestigious Experiential Learning Award , the Faculty Award of Excellence (Cestar-Lambton College, 2024), Twice nominated and awarded Excellence in Teaching Awards (Northeastern University, 2022, 2023, & 2024). He is also a recipient of the Innovation in Clinical Training Award and the Research Excellence Award (Canada, 2012 & 2016).

Dr. Alsayed is the author of 17+ peer-reviewed papers, practical guides, and analytical reviews on topics including clinical trial management, healthcare education, public health, and the transformative role of AI innovation in medicine.